Human induced pluripotent stem cell-derived cardiomyocytes

1 paper2 findings

1 lab in 1 country

Funders: Hokuto Foundation for Bioscience and 3 more

Animals1

Outcomes

2

Fibrosis

downin rats1

1 study

Human induced pluripotent stem cell-derived cardiomyocytes decrease fibrosis in rats.
“Transplantation of these pharmacologically rescued hiPSC-CMs significantly improved outcomes in infarcted hearts, including increased graft size, enhanced left ventricular function, reduced fibrosis”
Animalsrat myocardial infarction model
Senescence modulated cardiac repair with pluripotent stem cell-derived cardiomyocytes
Stem cell research & therapy10 Jun 2026

Left ventricular function

upin rats1

1 study

Human induced pluripotent stem cell-derived cardiomyocytes improve left ventricular function in rats.
“Transplantation of these pharmacologically rescued hiPSC-CMs significantly improved outcomes in infarcted hearts, including increased graft size, enhanced left ventricular function, reduced fibrosis”
Animalsrat myocardial infarction model
Senescence modulated cardiac repair with pluripotent stem cell-derived cardiomyocytes
Stem cell research & therapy10 Jun 2026

Latest

1 in 12 months

Stem Cell Research & Therapy11 Jun

Senescence modulated cardiac repair with pluripotent stem cell-derived cardiomyocytes

Experiments in ratsInterventions